{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:30:50Z","timestamp":1774870250463,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,8]]},"DOI":"10.7759\/cureus.61973","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T22:29:33Z","timestamp":1717885773000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Presentation of Ascites Secondary to Inferior Vena Cava Thrombosis in a Patient With Factor V Leiden Mutation"],"prefix":"10.7759","author":[{"given":"Sunpil","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dania","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Iskander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valvani","family":"Rachna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia","volume":"13","author":"Kujovich JL","year":"2011","unstructured":"Kujovich JL. Factor V Leiden thrombophilia. Genet Med. 2011, 13:1-16. 10.1097\/GIM.0b013e3181faa0f2","journal-title":"Genet Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)90064-1","article-title":"World distribution of factor V Leiden","volume":"347","author":"Dzimiri N","year":"1996","unstructured":"Dzimiri N, Meyer B. World distribution of factor V Leiden. Lancet. 1996, 347:481-2. 10.1016\/s0140-6736(96)90064-1","journal-title":"Lancet"},{"key":"ref3","article-title":"Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis","volume":"6","author":"Yusuf M","year":"2012","unstructured":"Yusuf M, Gupta A, Kumar A, Afreen S. Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis. Asian J Transfus Sci. 2012, 6:47-8.","journal-title":"Asian J Transfus Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-077909","article-title":"Advances in understanding pathogenic mechanisms of thrombophilic disorders","volume":"112","author":"Dahlb\u00e4ck B","year":"2008","unstructured":"Dahlb\u00e4ck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008, 112:19-27. 10.1182\/blood-2008-01-077909","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702063360602","article-title":"The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden)","volume":"336","author":"Simioni P","year":"1997","unstructured":"Simioni P, Prandoni P, Lensing AW, et al.. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med. 1997, 336:399-403. 10.1056\/NEJM199702063360602","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V93.8.2552","article-title":"Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V","volume":"93","author":"Thorelli E","year":"1999","unstructured":"Thorelli E, Kaufman RJ, Dahlb\u00e4ck B. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood. 1999, 93:2552-8.","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01117.x","article-title":"The incidence of venous thromboembolism among factor V Leiden carriers: a community-based cohort study","volume":"3","author":"Heit JA","year":"2005","unstructured":"Heit JA, Sobell JL, Li H, Sommer SS. The incidence of venous thromboembolism among factor V Leiden carriers: a community-based cohort study. J Thromb Haemost. 2005, 3:305-11. 10.1111\/j.1538-7836.2004.01117.x","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117623","article-title":"Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C","volume":"94","author":"Z\u00f6ller B","year":"1994","unstructured":"Z\u00f6ller B, Svensson PJ, He X, Dahlb\u00e4ck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 1994, 94:2521-4. 10.1172\/JCI117623","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615180","article-title":"Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight","volume":"80","author":"de Moerloose P","year":"1998","unstructured":"de Moerloose P, Wutschert R, Heinzmann M, Perneger T, Reber G, Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost. 1998, 80:239-41. 10.1055\/s-0037-1615180","journal-title":"Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3578","article-title":"Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis","volume":"107","author":"Dentali F","year":"2006","unstructured":"Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006, 107:2766-73. 10.1182\/blood-2005-09-3578","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.6.798","article-title":"Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis","volume":"40","author":"Mahmoud AE","year":"1997","unstructured":"Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut. 1997, 40:798-800. 10.1136\/gut.40.6.798","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20636","article-title":"Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis","volume":"8","author":"Zou Y","year":"2017","unstructured":"Zou Y, Zhang X, Zhang J, Ji X, Liu Y. Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis. Oncotarget. 2017, 8:75467-77. 10.18632\/oncotarget.20636","journal-title":"Oncotarget"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2008.01.004","article-title":"Etiology and VTE risk factor distribution in patients with inferior vena cava thrombosis","volume":"123","author":"Linnemann B","year":"2008","unstructured":"Linnemann B, Schmidt H, Schindewolf M, et al.. Etiology and VTE risk factor distribution in patients with inferior vena cava thrombosis. Thromb Res. 2008, 123:72-8. 10.1016\/j.thromres.2008.01.004","journal-title":"Thromb Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23785","article-title":"Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management","volume":"14","author":"Islam R","year":"2022","unstructured":"Islam R, Kundu S, Jha SB, et al.. Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management. cureus. 2022, 14:e23785. 10.7759\/cureus.23785","journal-title":"cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23784","article-title":"Risk of stroke with mitral stenosis: the underlying mechanism, treatment, and prevention","volume":"14","author":"Islam H","year":"2022","unstructured":"Islam H, Puttagunta SM, Islam R, et al.. Risk of stroke with mitral stenosis: the underlying mechanism, treatment, and prevention. Cureus. 2022, 14:e23784. 10.7759\/cureus.23784","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255899-a-rare-presentation-of-ascites-secondary-to-inferior-vena-cava-thrombosis-in-a-patient-with-factor-v-leiden-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T22:29:37Z","timestamp":1717885777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255899-a-rare-presentation-of-ascites-secondary-to-inferior-vena-cava-thrombosis-in-a-patient-with-factor-v-leiden-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.61973","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,8]]}}}